Dr. Shabih Hasan MD

The US Food and Drug Administration (FDA) recently passed a new drug called amantadine extended release capsules to treat dyskinesia in those who have Parkinson’s disease and  are also on medication therapy. The Michael J. Fox Foundation recently created the UNDRS or Unified Dyskinesia Rating...

What is sarcoidosis?Sarcoidosis is an inflammatory disease, which is characterized by the growth of granulomas or tiny collections of inflammatory cells in various parts of the body. When the immune system is slowed down and when these numerous clumps form, they tend to interfere with the organ’s...

Muscular dystrophy (MD) is a genetic disorder characterized by progressive muscle weakness and degeneration. MD is a progressive disorder which means that it worsens over time. It affects skeletal muscles that are responsible for controlling body movement and eventually affects other organs. There...

Teenager Victoria Da Conceicao is the CEO and founder of the Alzheimer’s organization named Brain Box. This initiative is a way for Victoria to fight for her grandmother who was diagnosed with Alzheimer’s. The initiative was first organized for Victoria’s grandmother, but it has since reached...

Mechanism of ActionSaphris is an atypical antipsychotic used for the treatment of schizophrenia and bipolar disorder in both adults and children ages 10 years old and above. The drug's exact mechanism of action is still unknown. However, it is believed that like other antipsychotics, it interferes...

Parkinson’s disease is a chronic, progressive movement disorder that affects the nervous system. It is characterized by gradual death and breakdown of nerve cells in the brain resulting in the decreased production of a chemical messenger called dopamine. Reduced dopamine levels cause abnormal...